Evidence map›Paper›PMID 41602368›Full record

ArticleFrontiers in oncology2025

Comparison of positioning errors and PTV expansion between the iSCOUT image-guidance system and onboard EPID in rectal cancer radiotherapy: a real-world study.

Bao Wan, Lu Hou, Jiangtao Han, Yongtai Zheng, Chao Liu, Shuo Sun, Yu Zhao, Fukui Huan, Hongkai Wang, Tantan Li

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Bao Wan *Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Lu Hou *Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Jiangtao Han *Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Yongtai ZhengDepartment of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Chao LiuDepartment of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Shuo SunDepartment of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Yu ZhaoDepartment of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Fukui HuanDepartment of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Hongkai Wang *Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Tantan Li *Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The iSCOUT orthogonal imaging system and onboard EPID system are commonly used for image-guidance positioning in conventional linear accelerators, but studies comparing the two are scarce. This research aims to analyze and compare the differences and consistency between the iSCOUT and onboard EPID systems in rectal cancer patients in the prone position. Methods: A retrospective analysis was conducted on 277 rectal cancer patients positioned prone on a Belly Board. During radiotherapy, at least three position verifications were performed in the first week, followed by weekly verifications. Both iSCOUT and onboard EPID image-guidance systems were used simultaneously for these verifications. Systematic and random errors, as well as the consistency of fixed positioning, were evaluated based on images from both systems taken in the same position. Patients were grouped by tumor location, BMI, age, and gender. The positioning errors and PTV (Planning Target Volume) margins for each group were calculated to analyze relevant patterns. Results: Kappa consistency in the leftright (LR) and superior-inferior (SI) directions was better compared to the anterior-posterior(AP) direction (LR = 0.794, SI = 0.852, AP = 0.610). Patients with tumors located in the upper rectal location require larger PTV expansions compared to those with middle or lower tumors. Obese patients with a BMI≥28 exhibited significantly larger PTV expansions than other groups. Age based grouping revealed an inverse relationship between age and PTV margin expansion. No significant differences were observed when grouped by gender. Discussion: The iSCOUT and EPID systems demonstrate good clinical agreement. Optimal PTV margins in rectal cancer radiotherapy should be individualized, with special consideration given to tumor location (upper rectum), high BMI, and advanced patient age.

Indexed as

image guidancepositioning errorPTV expansionradiotherapyrectal cancer

Identifiers

PMID41602368
PMCPMC12832534

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.